Anti-p43 monoclonal antibody

Drug Profile

Anti-p43 monoclonal antibody

Alternative Names: anti-PLF monoclonal antibody; CM-H-9; monoclonal antibody CMH9

Latest Information Update: 17 Sep 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Monoclonal antibodies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Graft-versus-host disease

Most Recent Events

  • 17 Sep 1999 No-Development-Reported for Graft-versus-host disease in Israel (Unknown route)
  • 09 May 1997 New profile
  • 09 May 1997 Preclinical development for Graft-versus-host disease in Israel (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top